Rosemarie Loffredo
Financieel Directeur/CFO bij The Leukemia & Lymphoma Society, Inc.
Profiel
Rosemarie Loffredo is currently the Chief Financial & Administrative Officer at The Leukemia & Lymphoma Society, Inc. She holds an MBA from The Trustees of Columbia University in The City of New York, a graduate degree from Boston College, and an undergraduate degree from Georgetown University.
Actieve functies van Rosemarie Loffredo
Bedrijven | Functie | Begin |
---|---|---|
The Leukemia & Lymphoma Society, Inc.
The Leukemia & Lymphoma Society, Inc. Miscellaneous Commercial ServicesCommercial Services The Leukemia & Lymphoma Society, Inc. operates as the world's largest voluntary health organization dedicated to funding blood cancer research, education and patient services. The firm provides treatment for , lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. It identifies and funds the most promising blood cancer research projects and forges partnerships with academic institutions, biotechnology and pharmaceutical companies to accelerate the development of new therapies. The company is headquartered in Rye Brook, NY. | Financieel Directeur/CFO | 24-07-2013 |
Opleiding van Rosemarie Loffredo
Georgetown University | Undergraduate Degree |
Boston College | Graduate Degree |
The Trustees of Columbia University in The City of New York | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
The Leukemia & Lymphoma Society, Inc.
The Leukemia & Lymphoma Society, Inc. Miscellaneous Commercial ServicesCommercial Services The Leukemia & Lymphoma Society, Inc. operates as the world's largest voluntary health organization dedicated to funding blood cancer research, education and patient services. The firm provides treatment for , lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. It identifies and funds the most promising blood cancer research projects and forges partnerships with academic institutions, biotechnology and pharmaceutical companies to accelerate the development of new therapies. The company is headquartered in Rye Brook, NY. | Commercial Services |